Facilitated By

San Antonio Medical Foundation

News

  • Initial public offerings scheduled to debut next week

    Business: Principal biotech developing immunotherapies for solid tumors. Tencent Music Entertainment - Shenzhen, China, 82 million shares, priced ...

  • Samsung Bioepis Announces Results of Additional One-Year Follow-Up Study Comparing Event ...

    The study results are being presented at the 2018 San Antonio Breast ... (SABCS) which is being held December 4-8, 2018 in San Antonio, Texas. ... KEYWORD: HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL.

  • Bb Biotech Ag Has Trimmed Its Regeneron Pharmaceuticals (REGN) Position; Oberweis Asset ...

    Bb Biotech Ag decreased Regeneron Pharmaceuticals Inc. (REGN) stake by ... Bb Biotech Ag sold 10,000 shares as Regeneron Pharmaceuticals Inc. .... Energy for project at Joint Base San Antonio – Seeking Alpha” published on ...

  • Moderna is sliding in its Wall Street debut after the biggest IPO in biotech history (MRNA, TBIO)

    Moderna Therapeutics just started trading, after the biggest initial public offering in biotech history. The stock slid 5.7 percent to $21.65 in its trading ...

  • Myriad study shows breast cancer recurrence test can predict therapy responses

    The studies were presented at the San Antonio Breast Cancer Symposium. A retrospective analysis of five prospective studies evaluated 3,746 ...